| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 3 | |
| #2 | United States | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Australia | 2 | |
| #5 | China | 2 | |
| #6 | Taiwan | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Morishita Ryuichi | 13 |
| #2 | Ogihara Toshio | 12 |
| #3 | Tomita Tetsuya | 5 |
| #4 | Nakamura Toshikazu | 5 |
| #5 | Ochi Takahiro | 5 |
| #6 | Taniyama Yoshiaki | 2 |
| #7 | Tanabe Tadashi | 1 |
| #8 | Aoki Motokuni | 1 |
| #9 | Yoshiaki Taniyama | 1 |
| #10 | Toshio Ogihara | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO0132220A1 | Gene therapy for diabetic ischemic disease | |
| WO0126694A1 | Gene therapy for cardiomyopathy | |
| CA2348906A1 | Gene therapy for cerebrovascular disorders | |
| AU4256800A | Medicament comprising HGF gene | |
| TW585775B | Medicament composition comprising HGF gene |